Roivant Sciences Ltd (ROIV) — Financial Flexibility Index
Roivant Sciences Ltd (ROIV) has a Financial Flexibility Index of -0.76x as of December 2025. Free cash flow of $-191.55 Million (operating CF $-196.48 Million minus capex $4.93 Million) represents -1% of total liabilities ($251.14 Million). Check how tangible is Roivant Sciences Ltd's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Roivant Sciences Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Roivant Sciences Ltd across 7 annual periods. For the full cash flow conversion analysis, see ROIV cash flow conversion.
Annual Financial Flexibility Index for Roivant Sciences Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Roivant Sciences Ltd. Explore Roivant Sciences Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.34x | $-834.85 Million | $-839.45 Million | $249.74 Million | ▼ -238.7% |
| 2024 | -0.99x | $-763.89 Million | $-765.27 Million | $773.95 Million | ▲ +7.1% |
| 2023 | -1.06x | $-830.70 Million | $-843.39 Million | $782.02 Million | ▲ +15.7% |
| 2022 | -1.26x | $-660.29 Million | $-677.73 Million | $523.70 Million | ▼ -21.8% |
| 2021 | -1.04x | $-546.33 Million | $-552.14 Million | $527.69 Million | ▲ +49.6% |
| 2020 | -2.05x | $-756.92 Million | $-761.83 Million | $368.36 Million | ▲ +8.6% |
| 2019 | -2.25x | $-1.01 Billion | $-1.02 Billion | $450.51 Million | — |